American International Group’s Repros Therapeutics Inc. RPRX Stock Holding History

American International Group’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,000	Closed	-$1K	–	5230
2016 Q1	$1K	Hold	1,000	–	–	﹤0.01%	5014
2015 Q4	$1K	Buy	+1,000	New	+$3.21K	﹤0.01%	4998
2015 Q2	–	Sell	-14,540	Closed	-$125K	–	5346
2015 Q1	$125K	Hold	14,540	–	–	﹤0.01%	3396
2014 Q4	$145K	Sell	14,540 -2,557	-15%	-$21.8K	﹤0.01%	3236
2014 Q3	$169K	Buy	17,097 +988	+6%	+$14.6K	﹤0.01%	3101
2014 Q2	$279K	Sell	16,109 -502	-3%	-$8.19K	﹤0.01%	2695
2014 Q1	$295K	Buy	16,611 +875	+6%	+$16.9K	﹤0.01%	2501
2013 Q4	$288K	Buy	15,736 +3,239	+26%	+$61.2K	﹤0.01%	2455
2013 Q3	$335K	Sell	12,497 -344	-3%	-$7.37K	﹤0.01%	2271
2013 Q2	$237K	Buy	+12,841	New	+$227K	﹤0.01%	2413

Other funds holding RPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

AIA

Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

American International Group's RPRX Position: Q2 2016 in Review

American International Group sold out of Repros Therapeutics Inc. (RPRX) in Q2 2016, closing a stake of 1,000 shares — an estimated $1K sold.

American International Group first reported a position in RPRX in Q2 2013 and held it in 10 quarters. The position peaked at $335K in Q3 2013. 43 funds tracked by Wall St. Rank hold RPRX as of Q2 2016.

American International Group reported no remaining Repros Therapeutics Inc. position as of Q2 2016 after selling out during the quarter.
American International Group sold 1,000 Repros Therapeutics Inc. shares in Q2 2016, an estimated $1K.
American International Group first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 10 quarters.
American International Group's Repros Therapeutics Inc. position peaked at $335K in Q3 2013.
43 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.